Literature DB >> 29628276

LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study.

G Pichler1, N Amigo2, M Tellez-Plaza3, M A Pardo-Cea4, A Dominguez-Lucas5, V G Marrachelli6, D Monleon6, J C Martin-Escudero7, J F Ascaso8, F J Chaves9, R Carmena8, J Redon10.   

Abstract

BACKGROUND: The association of low-density lipoprotein (LDL) particle composition with cardiovascular risk has not been explored before. The aim was to evaluate the relationship between baseline LDL particle size and composition (proportions of large, medium and small LDL particles over their sum expressed as small-LDL %, medium-LDL % and large-LDL %) and incident cardiovascular disease in a population-based study.
METHODS: Direct measurement of LDL particles was performed using a two-dimensional NMR-technique (Liposcale®). LDL cholesterol was assessed using both standard photometrical methods and the Liposcale® technique in a representative sample of 1162 adult men and women from Spain.
RESULTS: The geometric mean of total LDL particle concentration in the study sample was 827.2 mg/dL (95% CI 814.7, 839.8). During a mean follow-up of 12.4 ± 3.3 years, a total of 159 events occurred. Medium LDL particles were positively associated with all cardiovascular disease, coronary heart disease (CHD) and stroke after adjustment for traditional risk factors and treatment. Regarding LDL particle composition, the multivariable adjusted hazard ratios for CHD for a 5% increase in medium and small LDL % by a corresponding decrease of large LDL % were 1.93 (1.55, 2.39) and 1.41 (1.14, 1.74), respectively.
CONCLUSIONS: Medium LDL particles were associated with incident cardiovascular disease. LDL particles showed the strongest association with cardiovascular events when the particle composition, rather than the total concentration, was investigated. A change in baseline composition of LDL particles from large to medium and small LDL particles was associated with an increased cardiovascular risk, especially for CHD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; LDL particles; NMR metabolomics; Prospective study

Mesh:

Substances:

Year:  2018        PMID: 29628276     DOI: 10.1016/j.ijcard.2018.03.128

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  Cord Blood Advanced Lipoprotein Testing Reveals an Interaction between Gestational Diabetes and Birth-Weight and Suggests a New Early Biomarker of Infant Obesity.

Authors:  Francisco Algaba-Chueca; Elsa Maymó-Masip; Mónica Ballesteros; Albert Guarque; Alejandro Majali-Martínez; Olga Freixes; Núria Amigó; Sonia Fernández-Veledo; Joan Vendrell; Ana Megía
Journal:  Biomedicines       Date:  2022-04-29

2.  Acute phase protein response and changes in lipoprotein particle size in dogs with systemic inflammatory response syndrome.

Authors:  Erica Behling-Kelly; Carol E Haak; Patrick Carney; Jessica Waffle; Kelly Eaton; Robert Goggs
Journal:  J Vet Intern Med       Date:  2022-04-14       Impact factor: 3.175

3.  Impact of whole dairy matrix on musculoskeletal health and aging-current knowledge and research gaps.

Authors:  N R W Geiker; C Mølgaard; S Iuliano; R Rizzoli; Y Manios; L J C van Loon; J-M Lecerf; G Moschonis; J-Y Reginster; I Givens; A Astrup
Journal:  Osteoporos Int       Date:  2019-11-14       Impact factor: 4.507

4.  Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain.

Authors:  Maria Tellez-Plaza; Mercedes Sotos-Prieto; Mario Delgado-Velandia; Vannina Gonzalez-Marrachelli; Arce Domingo-Relloso; Marta Galvez-Fernandez; Maria Grau-Perez; Pablo Olmedo; Iñaki Galan; Fernando Rodriguez-Artalejo; Nuria Amigo; Laisa Briongos-Figuero; Josep Redon; Juan Carlos Martin-Escudero; Daniel Monleon-Salvado
Journal:  Int J Behav Nutr Phys Act       Date:  2022-01-27       Impact factor: 6.457

Review 5.  Dairy products and bone health.

Authors:  René Rizzoli
Journal:  Aging Clin Exp Res       Date:  2021-09-07       Impact factor: 3.636

6.  Precipitated sdLDL: An easy method to estimate LDL particle size.

Authors:  Bárbara Fernández-Cidón; Beatriz Candás-Estébanez; Josep Ribalta; Edmond Rock; Montserrat Guardiola-Guionnet; Núria Amigó; Ariadna Padró-Miquel; Pedro Alía-Ramos; Xavier Pintó-Sala
Journal:  J Clin Lab Anal       Date:  2020-03-21       Impact factor: 2.352

7.  Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles.

Authors:  Antonio J Amor; Esmeralda Castelblanco; Marta Hernández; Marga Gimenez; Minerva Granado-Casas; Jesús Blanco; Berta Soldevila; Enric Esmatjes; Ignacio Conget; Nuria Alonso; Emilio Ortega; Didac Mauricio
Journal:  Cardiovasc Diabetol       Date:  2020-08-09       Impact factor: 9.951

8.  Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial.

Authors:  Natia Peradze; Olivia M Farr; Nikolaos Perakakis; Iolanda Lázaro; Aleix Sala-Vila; Christos S Mantzoros
Journal:  Cardiovasc Diabetol       Date:  2019-10-31       Impact factor: 9.951

9.  Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area.

Authors:  Marina Idalia Rojo-López; Esmeralda Castelblanco; Jordi Real; Marta Hernández; Mireia Falguera; Núria Amigó; Josep Julve; Núria Alonso; Josep Franch-Nadal; Minerva Granado-Casas; Dídac Mauricio
Journal:  Nutrients       Date:  2021-12-06       Impact factor: 5.717

10.  Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients.

Authors:  Marcelino Bermudez-Lopez; Hector Perpiñan; Nuria Amigo; Eva Castro; Nuria Alonso; Didac Mauricio; Elvira Fernandez; Jose M Valdivielso
Journal:  Clin Kidney J       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.